Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,647,265 | 1,584,156 | 1,072,386 | 816,158 | 815,448 |
| Receivables | 684,507 | 632,775 | 775,371 | 735,433 | 443,172 |
| Inventories | 226,524 | 225,730 | 237,434 | 258,676 | 238,306 |
| TOTAL | $2,947,731 | $2,799,767 | $2,413,921 | $2,175,380 | $1,831,368 |
| Non-Current Assets | |||||
| PPE Net | 295,147 | 292,298 | 285,837 | 220,142 | 201,857 |
| Intangibles | 3,938,688 | 4,026,827 | 4,120,166 | 4,188,740 | 4,286,609 |
| Other Non-Current Assets | 1,558,772 | 1,558,836 | 1,788,764 | 1,623,154 | 1,526,776 |
| TOTAL | $5,792,607 | $5,877,961 | $6,194,767 | $6,032,036 | $6,015,242 |
| Total Assets | $8,740,338 | $8,677,728 | $8,608,688 | $8,207,416 | $7,846,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Accounts payable and accrued liabilities | 67,014 | 30,125 | 50,724 | 51,947 | 42,986 |
| Accrued Expenses | 377,433 | 523,015 | 483,833 | 478,499 | 389,626 |
| TOTAL | $825,179 | $886,571 | $854,043 | $852,810 | $773,844 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,552,741 | 2,555,233 | 2,557,864 | 2,560,444 | 2,562,517 |
| Other Non-Current Liabilities | 209,811 | 173,076 | 155,015 | 171,448 | 131,072 |
| TOTAL | $3,097,330 | $3,118,764 | $3,304,431 | $3,280,970 | $3,217,996 |
| Total Liabilities | $3,922,509 | $4,005,335 | $4,158,474 | $4,133,780 | $3,991,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 229,884 | 229,167 | 226,821 | 225,893 | 224,769 |
| Common Shares | 23 | 23 | 22 | 22 | 22 |
| Retained earnings | 522,866 | 318,605 | 145,423 | -181,120 | -339,237 |
| Other shareholders' equity | -14,707 | -14,572 | -1,117 | -603 | -838 |
| TOTAL | $4,817,829 | $4,672,393 | $4,450,214 | $4,073,636 | $3,854,770 |
| Total Liabilities And Equity | $8,740,338 | $8,677,728 | $8,608,688 | $8,207,416 | $7,846,610 |